Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment

Thumbnail Image

Date

2013

Authors

Farrugia, Albert
Cassar, J
Kimber, M. C.
Bansal, M.
Fischer, K.
Auserswald, G.
O'Mahony, B
Tolley, K.
Noone, D.
Balboni, S.

Journal Title

Journal ISSN

Volume Title

Publisher

Blackwell Publishing Ltd

Abstract

Prophylaxis has been established as the treatment of choice in children with haemophilia and its continuation into the adult years has been shown to decrease morbidity throughout life. The cost of factor therapy has made the option questionable in cost-ef

Description

Keywords

Keywords: activated prothrombin complex; blood clotting factor 8 concentrate; recombinant blood clotting factor 8; adolescent; adult; article; child; comparative study; cost effectiveness analysis; cost utility analysis; female; hemophilia A; human; immunological t Cost-utility; Health economics; Prophylaxis

Citation

URI

http://hdl.handle.net/1885/74520

Collections

ANU Research Publications

Source

Haemophilia

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

DOI

10.1111/hae.12121

Restricted until

2037-12-31

Downloads

File
Description
01_Farrugia_Treatment_for_life_for_severe_2013.pdf (307.43 KB)

DSpace software copyright © 2002-2026 LYRASIS

abcd